Your browser doesn't support javascript.
Quinoline-based Compounds as Key Candidates to Tackle Drug Discovery Programs of Microbicidal Agents.
da Gama, Aline N Silva; Soeiro, Maria N C.
  • da Gama ANS; Laboratorio de Biologia Celular, Instituto Oswaldo Cruz, Fundacao Oswaldo Cruz, Rio de Janeiro, Brazil.
  • Soeiro MNC; Laboratorio de Biologia Celular, Instituto Oswaldo Cruz, Fundacao Oswaldo Cruz, Rio de Janeiro, Brazil.
Curr Pharm Des ; 27(15): 1757-1762, 2021.
Article in English | MEDLINE | ID: covidwho-836067
ABSTRACT
Quinolines are heterocyclic nitrogen compounds, ubiquitous in nature and largely used as a structural component of dyes, solvent for resins, terpenes as well as during the production of several other chemical stuffs, including pesticides. Quinolines, such as quinine and chloroquine, exhibit various pharmacological properties, acting as antimalarial drugs, antiparasitic, antibacterial, antiviral, antifungal, and anticancer agents, besides being in clinical use for autoimmune diseases. A brief review has been presented regarding the biological effect and clinical use of quinolines and derivatives upon three trypanosomatids agents of important neglected tropical diseases; Trypanosoma cruzi, Trypanosoma brucei spp and Leishmania spp, which trigger Chagas disease, sleeping sickness and leishmaniasis, respectively, also extending to a glance update of their potential application towards other microbes relevant for emerging illness caused by fungi, bacteria and virus, including the pandemic Covid-19.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Quinolines / Trypanosoma cruzi / COVID-19 / Antiprotozoal Agents Type of study: Prognostic study Limits: Humans Language: English Journal: Curr Pharm Des Journal subject: Pharmacy Year: 2021 Document Type: Article Affiliation country: 1381612826666201006125644

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Quinolines / Trypanosoma cruzi / COVID-19 / Antiprotozoal Agents Type of study: Prognostic study Limits: Humans Language: English Journal: Curr Pharm Des Journal subject: Pharmacy Year: 2021 Document Type: Article Affiliation country: 1381612826666201006125644